Dexetimide: Clinical Trials

9 trials of Dexetimide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown, 1 terminated. 9 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 6, Unknown 2, Terminated 1
Phase 33Completed 1, Terminated 1, Unknown 1

Follow Dexetimide: new trials by email Literature Review of Dexetimide trials Research Report on Dexetimide

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cortical Ischemic Stroke and Serotonin
Serotonin Uptake Inhibitors, Placebo - Stroke
Phase 2UnknownInsel Gruppe AG, University Hospital Bern902016-08-012020-03-06
The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
Escitalopram, placebo - GBM, Depression
Phase 2 / Phase 3UnknownTel-Aviv Sourasky Medical Center1002015-12-012015-12-07
The Efficacy of Citalopram Treatment in Acute Stroke
Citalopram, Placebo - Stroke, Ischemic
Phase 2CompletedUniversity of Aarhus6422013-09-012017-02-24
EScitalopram PIndolol ONset of Action
escitalopram, pindolol, escitalopram - Unipolar Depression
Phase 2 / Phase 3TerminatedMarkus KOSEL182010-10-012015-05-27
Flushing in Social Anxiety Disorder on Cipralex
Cipralex, Placebo - Social Anxiety Disorder
Phase 2CompletedSTART Clinic for Mood and Anxiety Disorders712008-10-012013-10-30
A Study for Participants With Major Depression
LY2216684, Placebo, Escitalopram - Major Depressive Disorder
Phase 2CompletedEli Lilly and Company4692006-12-012018-04-27
Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression
S-citalopram, Cognitive behavioral therapy (CBT), TRODAT-1 single photon emission computed tomographic (SPECT) imaging - Depression
Phase 2 / Phase 3CompletedUniversity of Pennsylvania662005-10-012020-04-16
Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients
Escitalopram, Placebo - Major Depressive Disorder, Hepatitis C, Chronic
Phase 2CompletedGermans Trias i Pujol Hospital1332005-03-012020-08-17
Citalopram in Irritable Bowel Syndrome
Citalopram, Placebo - Irritable Bowel Syndrome
Phase 2CompletedStanford University542001-04-012017-04-17

Conditions studied

Depression (3)  ·  Depressive Disorder, Major (2)  ·  Stroke (2)  ·  Depressive Disorder (1)  ·  Hepatitis C, Chronic (1)  ·  Irritable Bowel Syndrome (1)  ·  Ischemic Stroke (1)  ·  Phobia, Social (1)

Sponsors

Eli Lilly and Company (1)  ·  Germans Trias i Pujol Hospital (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Markus KOSEL (1)  ·  START Clinic for Mood and Anxiety Disorders (1)  ·  Stanford University (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  University of Aarhus (1)  ·  University of Pennsylvania (1)

Countries

United States (3)  ·  Switzerland (2)  ·  Canada (1)  ·  Denmark (1)  ·  Israel (1)  ·  Romania (1)  ·  Spain (1)

Top investigators

Boris Modrau, M.D. (1)  ·  Crisanto Diez-Quevedo, MD (1)  ·  Grethe Andersen, DSMc (1)  ·  Helle Iversen, DSMc (1)  ·  Jay D. Amsterdam, MD (1)  ·  Kristian L Kraglund, M.D. (1)  ·  Markus Kosel, MD-PhD (1)  ·  Martin A Katzman, MD (1)  ·  Rachel Grossman, MD (1)  ·  Ramon Planas, MD (1)  ·  Roland Wiest (1)  ·  Uri Ladabaum, M.D., M.S. (1)

Results publications

PMID 21034680, PMID 30355209, PMID 33032615, PMID 36997260

NIH funding

2016 (1), R34MH070753 (1)